Search - tctmd.com

Displaying 161 - 180 of 184

Sort: Relevancy | Date

News Daily News

ROCKET AF Analysis Looks at Stroke Risk After Stopping Anticoagulation

February 04, 2013

News Daily News

El ROCKET AF Analiza el Riesgo de ACV tras Interrumpir la Anticoagulación

February 04, 2013

News Industry News

8500+ Patient Trial Validates Association between High Platelet Reactivity and 1-Year Cardiovascular Outcomes at TCT 2012

October 25, 2012

News Daily News

El Apixaban Supera a la Warfarina a Todos los Niveles de Riesgo en Pacientes con FA

Caitlin E. Cox

October 04, 2012

News Daily News

Apixaban Surpasses Warfarin At All Risk Levels in A-Fib Patients

Caitlin E. Cox

October 04, 2012

News Daily News

Todavía No se ha Cerrado la Puerta del CLOSURE I

Yael L. Maxwell

June 15, 2012

News Daily News

Door Still Not Shut on CLOSURE I

Yael L. Maxwell

June 15, 2012

News Daily News

Rivaroxaban May be Cost-Effective for A-fib Patients

L.A. McKeown

June 06, 2012

News Daily News

El Rivaroxaban podría ser Rentable en Pacientes con Fibrilación Auricular

L.A. McKeown

June 06, 2012

News Daily News

ROCKET AF: Stopping Rivaroxaban or Warfarin Equally Harmful in A-fib Patients

Caitlin E. Cox

April 26, 2012

News Daily News

ROCKET AF: Interrumpir la Toma de Rivaroxaban o Warfarina es Igual de Perjudicial en Pacientes con Fibrilación Auricular

Caitlin E. Cox

April 26, 2012

News Conference News ACC 2012

Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism

L.A. McKeown

March 26, 2012

News Daily News

SCAI Publishes Cath Lab Best Practices

March 22, 2012

News Daily News

SCAI Publica las Mejores Prácticas de los Laboratorios de Cateterismo

March 22, 2012

News Daily News

Se Publica el CLOSURE I mientras siguen en Marcha Similares Ensayos del FOV

Caitlin E. Cox

March 15, 2012

News Daily News

CLOSURE I Published as Similar PFO Trials Forge Ahead

Caitlin E. Cox

March 15, 2012

News Daily News

Catheter-Directed Thrombolysis Beneficial for Proximal DVT

Yael L. Maxwell

December 12, 2011

News Daily News

Rivaroxaban Continues Emergence of New Class of Anticoagulants for A-Fib

Caitlin E. Cox

September 14, 2011

News Conference News

Novel Anticoagulants Showing Benefits in A-fib Subgroups

August 29, 2011

News Conference News

Apixaban Bests Warfarin in Stroke Prevention for Atrial Fib

August 28, 2011

Advertisement

ROCKET AF Analysis Looks at Stroke Risk After Stopping Anticoagulation

El ROCKET AF Analiza el Riesgo de ACV tras Interrumpir la Anticoagulación

8500+ Patient Trial Validates Association between High Platelet Reactivity and 1-Year Cardiovascular Outcomes at TCT 2012

El Apixaban Supera a la Warfarina a Todos los Niveles de Riesgo en Pacientes con FA

Apixaban Surpasses Warfarin At All Risk Levels in A-Fib Patients

Todavía No se ha Cerrado la Puerta del CLOSURE I

Door Still Not Shut on CLOSURE I

Rivaroxaban May be Cost-Effective for A-fib Patients

El Rivaroxaban podría ser Rentable en Pacientes con Fibrilación Auricular

ROCKET AF: Stopping Rivaroxaban or Warfarin Equally Harmful in A-fib Patients

ROCKET AF: Interrumpir la Toma de Rivaroxaban o Warfarina es Igual de Perjudicial en Pacientes con Fibrilación Auricular

Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism

SCAI Publishes Cath Lab Best Practices

SCAI Publica las Mejores Prácticas de los Laboratorios de Cateterismo

Se Publica el CLOSURE I mientras siguen en Marcha Similares Ensayos del FOV

CLOSURE I Published as Similar PFO Trials Forge Ahead

Catheter-Directed Thrombolysis Beneficial for Proximal DVT

Rivaroxaban Continues Emergence of New Class of Anticoagulants for A-Fib

Novel Anticoagulants Showing Benefits in A-fib Subgroups

Apixaban Bests Warfarin in Stroke Prevention for Atrial Fib

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content